Sort
1,049,261 grants matching “t cell”
Oxidized Phospholipids in Vascular Pathobiology
$2,281,679Roy L Silverstein · Cleveland Clinic Lerner Com-Cwru · P01 · FY2009 · HL
Protection against Type I diabetes by parasitic helminths
$2,281,500Edward E Mitre · Henry M. Jackson Fdn For The Adv Mil/Med · DP2 · FY2008 · DK
Macrophage Plasticity in Inflammatory Lung Injury
$2,281,477Asrar B. Malik · University Of Illinois At Chicago · P01 · FY2021 · HL
Stem Cell Biology: New Directions in Clinical and Basic Research
$2,281,382Peter J Quesenberry · Rhode Island Hospital · P20 · FY2012 · GM
Comprhensive analysis of functional RNA elements encoded in the human genome
$2,281,350Brenton R Graveley · University Of Connecticut Sch Of Med/Dnt · U54 · FY2014 · HG
Nebraska Center for Integrated Biomolecular Communication (CIBC)
$2,281,340James M Takacs · University Of Nebraska Lincoln · P20 · FY2019 · GM
Nebraska Center for Integrated Biomolecular Communication (CIBC)
$2,281,338James M Takacs · University Of Nebraska Lincoln · P20 · FY2020 · GM
Architecture and control of exocytosis and endocytosis in excitable cells
$2,281,322Justin Taraska · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Vaccine Induced Immunity in the Young and Aged
$2,281,308Rafi Ahmed · Emory University · U19 · FY2020 · AI
Oxidized Phospholipids in Vascular Pathobiology
$2,281,238Roy L Silverstein · Cleveland Clinic Lerner Com-Cwru · P01 · FY2010 · HL
Integrative Oncogenomics of Multiple Myeloma
$2,281,230Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2024 · CA
Genomics of Gene Regulation in Progenitor to Differentiated Keratinocytes
$2,281,186Michael P Snyder · Stanford University · U01 · FY2017 · HG
Contraception development research center to advance a novel intravaginal ring as a non-hormonal multipurpose prevention technology
$2,281,160Lisa Blake Haddad · Population Council · P50 · FY2025 · HD
Ancillary Study
$2,281,109Joshua A Boyce · Brigham And Women'S Hospital · U01 · FY2012 · HL
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
$2,281,096Song Yao · Roswell Park Cancer Institute Corp · UH3 · FY2024 · CA
University of Washington Center for Nuclear Organization and Function
$2,281,092Jay Ashok Shendure · University Of Washington · U54 · FY2015 · DK
Oxidized Phospholipids in Vascular Pathobiology
$2,280,783Thomas M McIntyre · Cleveland Clinic Lerner Com-Cwru · P01 · FY2011 · HL
Mechanisms that Govern Cardiomyocyte Proliferation and Remuscularization following Ventricular Injury
$2,280,760Jianyi Zhang · University Of Alabama At Birmingham · P01 · FY2024 · HL
Calcium signaling in the cerebrovascular unit in health and disease
$2,280,393Mark T Nelson · University Of Vermont & St Agric College · P01 · FY2014 · HL
DNA Sequencing and FACS Core Facilities
$2,280,383Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Novel fibril-selective nanobody-based agents targeting intracellular and extracellular α-synuclein aggregates and prion-like propagation induced dementia
$2,280,379Wenjing Wang · University Of Michigan At Ann Arbor · RF1 · FY2024 · NS
COBRE in Lipidomics and Pathobiology
$2,280,308Lina M Obeid · Medical University Of South Carolina · P20 · FY2006 · RR
SPORE: Targeted Therapies for Glioma
$2,280,112Tracy T Batchelor · Massachusetts General Hospital · P50 · FY2017 · CA
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes - Biostatistics Research Center
$2,280,003Barbara Halina Braffett · George Washington University · U01 · FY2023 · DK
MICRORNA AND NEURAL FACTOR-MEDIATED DIRECT REPROGRAMMING OF CELL FATES
$2,280,000Andrew Yoo · Washington University · DP2 · FY2012 · NS